{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:57:03Z","timestamp":1780484223854,"version":"3.54.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00415-020-10297-5","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T10:02:51Z","timestamp":1605088971000},"page":"4630-4645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Spinocerebellar ataxia type 23 (SCA23): a review"],"prefix":"10.1007","volume":"268","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidi","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5430-833X","authenticated-orcid":false,"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"issue":"8334","key":"10297_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"1","author":"AE Harding","year":"1983","unstructured":"Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1(8334):1151\u20131155","journal-title":"Lancet"},{"issue":"2","key":"10297_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00415-018-9076-4","volume":"266","author":"R Sullivan","year":"2019","unstructured":"Sullivan R, Yau WY, O\u2019Connor E, Houlden H (2019) Spinocerebellar ataxia: an update. J Neurol 266(2):533\u2013544","journal-title":"J Neurol"},{"issue":"10","key":"10297_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrn.2017.92","volume":"18","author":"HL Paulson","year":"2017","unstructured":"Paulson HL, Shakkottai VG, Clark HB, Orr HT (2017) Polyglutamine spinocerebellar ataxias\u2014from genes to potential treatments. Nat Rev Neurosci 18(10):613\u2013626","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"10297_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/gim.2013.28","volume":"15","author":"S Jayadev","year":"2013","unstructured":"Jayadev S, Bird TD (2013) Hereditary ataxias: overview. Genet Med 15(9):673\u2013683","journal-title":"Genet Med"},{"key":"10297_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/B978-0-444-51892-7.00038-3","volume":"103","author":"E Storey","year":"2012","unstructured":"Storey E, Gardner RJ (2012) Spinocerebellar ataxia type 20. Handb Clin Neurol 103:567\u2013573","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10297_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neulet.2010.05.089","volume":"479","author":"Y Yuan","year":"2010","unstructured":"Yuan Y, Zhou X, Ding F, Liu Y, Tu J (2010) Molecular genetic analysis of a new form of spinocerebellar ataxia in a Chinese Han family. Neurosci Lett 479(3):321\u2013326","journal-title":"Neurosci Lett"},{"key":"10297_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ymeth.2015.11.017","volume":"98","author":"MO Urbanek","year":"2016","unstructured":"Urbanek MO, Krzyzosiak WJ (2016) RNA FISH for detecting expanded repeats in human diseases. Methods 98:115\u2013123","journal-title":"Methods"},{"issue":"2","key":"10297_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mds.26059","volume":"30","author":"JO Johnson","year":"2015","unstructured":"Johnson JO, Stevanin G, van de Leemput J, Hernandez DG, Arepalli S, Forlani S et al (2015) A 7.5-Mb duplication at chromosome 11q21\u201311q22.3 is associated with a novel spastic ataxia syndrome. Mov Disord 30(2):262\u2013266","journal-title":"Mov Disord"},{"issue":"2","key":"10297_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/187221512801327442","volume":"6","author":"A Trott","year":"2012","unstructured":"Trott A, Houenou LJ (2012) Mini-review: spinocerebellar ataxias: an update of SCA genes. Recent Pat DNA Gene Seq 6(2):115\u2013121","journal-title":"Recent Pat DNA Gene Seq"},{"issue":"Pt 11","key":"10297_CR10","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/brain\/awh276","volume":"127","author":"DS Verbeek","year":"2004","unstructured":"Verbeek DS, van de Warrenburg BP, Wesseling P, Pearson PL, Kremer HP, Sinke RJ (2004) Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13\u201312.3. Brain 127(Pt 11):2551\u20132557","journal-title":"Brain"},{"issue":"5","key":"10297_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ajhg.2010.10.001","volume":"87","author":"G Bakalkin","year":"2010","unstructured":"Bakalkin G, Watanabe H, Jezierska J, Depoorter C, Verschuuren-Bemelmans C, Bazov I et al (2010) Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. Am J Hum Genet 87(5):593\u2013603","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10297_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00415-012-6721-1","volume":"260","author":"K Fawcett","year":"2013","unstructured":"Fawcett K, Mehrabian M, Liu YT, Hamed S, Elahi E, Revesz T et al (2013) The frequency of spinocerebellar ataxia type 23 in a UK population. J Neurol 260(3):856\u2013859","journal-title":"J Neurol"},{"issue":"1","key":"10297_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neulet.2012.08.062","volume":"528","author":"YT Liu","year":"2012","unstructured":"Liu YT, Tang BS, Wang JL, Guan WJ, Shen L, Shi YT et al (2012) Spinocerebellar ataxia type 23 is an uncommon SCA subtype in the Chinese Han population. Neurosci Lett 528(1):51\u201354","journal-title":"Neurosci Lett"},{"issue":"7","key":"10297_CR14","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00415-013-6882-6","volume":"260","author":"J Jezierska","year":"2013","unstructured":"Jezierska J, Stevanin G, Watanabe H, Fokkens MR, Zagnoli F, Kok J et al (2013) Identification and characterization of novel PDYN mutations in dominant cerebellar ataxia cases. J Neurol 260(7):1807\u20131812","journal-title":"J Neurol"},{"key":"10297_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.irn.2018.09.011","volume":"143","author":"M Mascalchi","year":"2018","unstructured":"Mascalchi M, Vella A (2018) Neuroimaging applications in chronic ataxias. Int Rev Neurobiol 143:109\u2013162","journal-title":"Int Rev Neurobiol"},{"issue":"11","key":"10297_CR16","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/j.acra.2018.12.015","volume":"26","author":"K Ito","year":"2019","unstructured":"Ito K, Ohtsuka C, Yoshioka K, Maeda T, Yokosawa S, Mori F et al (2019) Differentiation between multiple system atrophy and other spinocerebellar degenerations using diffusion kurtosis imaging. Acad Radiol 26(11):e333\u2013e339","journal-title":"Acad Radiol"},{"issue":"1","key":"10297_CR17","doi-asserted-by":"publisher","first-page":"17329","DOI":"10.1038\/s41598-019-53980-y","volume":"9","author":"M Kim","year":"2019","unstructured":"Kim M, Ahn JH, Cho Y, Kim JS, Youn J, Cho JW (2019) Differential value of brain magnetic resonance imaging in multiple system atrophy cerebellar phenotype and spinocerebellar ataxias. Sci Rep 9(1):17329","journal-title":"Sci Rep"},{"issue":"6","key":"10297_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/gim.2014.122","volume":"17","author":"Y Xue","year":"2015","unstructured":"Xue Y, Ankala A, Wilcox WR, Hegde MR (2015) Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome\/genome sequencing. Genet Med 17(6):444\u2013451","journal-title":"Genet Med"},{"issue":"4","key":"10297_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","volume":"10","author":"CS Richards","year":"2008","unstructured":"Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR et al (2008) ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med 10(4):294\u2013300","journal-title":"Genet Med"},{"key":"10297_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1172-6-33","volume":"6","author":"NR Whaley","year":"2011","unstructured":"Whaley NR, Fujioka S, Wszolek ZK (2011) Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics. Orphanet J Rare Dis 6:33","journal-title":"Orphanet J Rare Dis"},{"key":"10297_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/B978-0-444-64189-2.00010-X","volume":"155","author":"BW Soong","year":"2018","unstructured":"Soong BW, Morrison PJ (2018) Spinocerebellar ataxias. Handb Clin Neurol 155:143\u2013174","journal-title":"Handb Clin Neurol"},{"issue":"12","key":"10297_CR22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s40263-014-0200-4","volume":"28","author":"J van Gaalen","year":"2014","unstructured":"van Gaalen J, Kerstens FG, Maas RP, H\u00e4rmark L, van de Warrenburg BP (2014) Drug-induced cerebellar ataxia: a systematic review. CNS Drugs 28(12):1139\u20131153","journal-title":"CNS Drugs"},{"issue":"3","key":"10297_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1590\/0004-282x20190020","volume":"77","author":"JL Pedroso","year":"2019","unstructured":"Pedroso JL, Vale TC, Braga-Neto P, Dutra LA, Fran\u00e7a MC, Jr., Teive H A G, et al (2019) Acute cerebellar ataxia: differential diagnosis and clinical approach. Arq Neuropsiquiatr 77(3):184\u2013193","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"10297_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4183\/aeb.2016.77","volume":"12","author":"SK Kotwal","year":"2016","unstructured":"Kotwal SK, Kotwal S, Gupta R, Singh JB, Mahajan A (2016) Cerebellar ataxia as a presenting feature of hypothyroidism. Acta Endocrinol (Buchar) 12(1):77\u201379","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"5","key":"10297_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.5144\/0256-4947.2014.440","volume":"34","author":"TA Elhadd","year":"2014","unstructured":"Elhadd TA, Linton K, McCoy C, Saha S, Holden R (2014) A hitherto undescribed case of cerebellar ataxia as the sole presentation of thyrotoxicosis in a young man: a plausible association. Ann Saudi Med 34(5):440\u2013443","journal-title":"Ann Saudi Med"},{"key":"10297_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1333","author":"DS Moore","year":"2017","unstructured":"Moore DS (2017) Behavioral epigenetics. Wiley Interdiscip Rev Syst Biol Med. https:\/\/doi.org\/10.1002\/wsbm.1333","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"1","key":"10297_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nan.12608","volume":"46","author":"S Rd","year":"2020","unstructured":"Rd S, Dr C, H S, (2020) Invited review: epigenetics in neurodevelopment. Neuropathol Appl Neurobiol 46(1):6\u201327","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"10297_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molcel.2017.10.030","volume":"69","author":"ZH Harvey","year":"2018","unstructured":"Harvey ZH, Chen Y, Jarosz DF (2018) Protein-based inheritance: epigenetics beyond the chromosome. Mol Cell 69(2):195\u2013202","journal-title":"Mol Cell"},{"issue":"1","key":"10297_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ije\/dyr184","volume":"41","author":"CH Waddington","year":"2012","unstructured":"Waddington CH (2012) The epigenotype. Int J Epidemiol 41(1):10\u201313","journal-title":"Int J Epidemiol"},{"key":"10297_CR30","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018200","author":"G Felsenfeld","year":"2014","unstructured":"Felsenfeld G (2014) A brief history of epigenetics. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a018200","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10297_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/hdy.2010.66","volume":"105","author":"C Biemont","year":"2010","unstructured":"Biemont C (2010) From genotype to phenotype. What do epigenetics and epigenomics tell us? Heredity (Edinb) 105(1):1\u20133","journal-title":"Heredity (Edinb)"},{"issue":"9","key":"10297_CR32","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1093\/cercor\/bhx181","volume":"28","author":"I Bazov","year":"2018","unstructured":"Bazov I, Sarkisyan D, Kononenko O, Watanabe H, Taqi MM, Stalhandske L et al (2018) Neuronal expression of opioid gene is controlled by dual epigenetic and transcriptional mechanism in human brain. Cereb Cortex 28(9):3129\u20133142","journal-title":"Cereb Cortex"},{"issue":"8","key":"10297_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.bbagrm.2014.03.001","volume":"1839","author":"SB Rothbart","year":"2014","unstructured":"Rothbart SB, Strahl BD (2014) Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 1839(8):627\u2013643","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10297_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrg2005","volume":"8","author":"M Esteller","year":"2007","unstructured":"Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8(4):286\u2013298","journal-title":"Nat Rev Genet"},{"issue":"11","key":"10297_CR35","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ncb3629","volume":"19","author":"MA Reid","year":"2017","unstructured":"Reid MA, Dai Z, Locasale JW (2017) The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat Cell Biol 19(11):1298\u20131306","journal-title":"Nat Cell Biol"},{"key":"10297_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcdb.2019.09.008","volume":"97","author":"S Safi-Stibler","year":"2020","unstructured":"Safi-Stibler S, Gabory A (2020) Epigenetics and the developmental origins of health and disease: parental environment signalling to the epigenome, critical time windows and sculpting the adult phenotype. Semin Cell Dev Biol 97:172\u2013180","journal-title":"Semin Cell Dev Biol"},{"issue":"7766","key":"10297_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Heard E (2019) Advances in epigenetics link genetics to the environment and disease. Nature 571(7766):489\u2013499","journal-title":"Nature"},{"issue":"suppl_1","key":"10297_CR38","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1093\/advances\/nmy078","volume":"10","author":"A Cuevas-Sierra","year":"2019","unstructured":"Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA (2019) Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications. Adv Nutr 10(suppl_1):S17\u2013S30. https:\/\/doi.org\/10.1093\/advances\/nmy078","journal-title":"Adv Nutr"},{"key":"10297_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/nu9090962","author":"K Aleksandrova","year":"2017","unstructured":"Aleksandrova K, Romero-Mosquera B, Hernandez V (2017) Diet, gut microbiome and epigenetics: emerging links with inflammatory bowel diseases and prospects for management and prevention. Nutrients. https:\/\/doi.org\/10.3390\/nu9090962","journal-title":"Nutrients"},{"issue":"1","key":"10297_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2012.11.006","volume":"23","author":"SA Bert","year":"2013","unstructured":"Bert SA, Robinson MD, Strbenac D, Statham AL, Song JZ, Hulf T et al (2013) Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell 23(1):9\u201322","journal-title":"Cancer Cell"},{"issue":"5595","key":"10297_CR41","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1076997","volume":"298","author":"R Cao","year":"2002","unstructured":"Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P et al (2002) Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 298(5595):1039\u20131043","journal-title":"Science"},{"key":"10297_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40673-020-00117-x","volume":"7","author":"S Satoh","year":"2020","unstructured":"Satoh S, Kondo Y, Ohara S, Yamaguchi T, Nakamura K, Yoshida K (2020) Intrafamilial phenotypic variation in spinocerebellar ataxia type 23. Cerebellum Ataxias 7:7","journal-title":"Cerebellum Ataxias"},{"issue":"3","key":"10297_CR43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42(3):174\u2013183","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10297_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1399-0004.2011.01651.x","volume":"80","author":"J Schicks","year":"2011","unstructured":"Schicks J, Synofzik M, Beetz C, Schiele F, Sch\u00f6ls L (2011) Mutations in the PDYN gene (SCA23) are not a frequent cause of dominant ataxia in Central Europe. Clin Genet 80(5):503\u2013504","journal-title":"Clin Genet"},{"issue":"3","key":"10297_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/mds.24064","volume":"27","author":"BL Fogel","year":"2012","unstructured":"Fogel BL, Lee JY, Lane J, Wahnich A, Chan S, Huang A et al (2012) Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia. Mov Disord 27(3):442\u2013446","journal-title":"Mov Disord"},{"issue":"3","key":"10297_CR46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.parkreldis.2014.12.028","volume":"21","author":"K Saigoh","year":"2015","unstructured":"Saigoh K, Mitsui J, Hirano M, Shioyama M, Samukawa M, Ichikawa Y et al (2015) The first Japanese familial case of spinocerebellar ataxia 23 with a novel mutation in the PDYN gene. Parkinsonism Relat Disord 21(3):332\u2013334","journal-title":"Parkinsonism Relat Disord"},{"key":"10297_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2741\/1522","volume":"10","author":"KF Hauser","year":"2005","unstructured":"Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED et al (2005) Pathobiology of dynorphins in trauma and disease. Front Biosci 10:216\u2013235","journal-title":"Front Biosci"},{"issue":"2","key":"10297_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrn1845","volume":"7","author":"M Ludwig","year":"2006","unstructured":"Ludwig M, Leng G (2006) Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 7(2):126\u2013136","journal-title":"Nat Rev Neurosci"},{"key":"10297_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbr.2016.11.050","volume":"320","author":"LV Riters","year":"2017","unstructured":"Riters LV, Cordes MA, Stevenson SA (2017) Prodynorphin and kappa opioid receptor mRNA expression in the brain relates to social status and behavior in male European starlings. Behav Brain Res 320:37\u201347","journal-title":"Behav Brain Res"},{"key":"10297_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0690-z","author":"DW Bloodgood","year":"2020","unstructured":"Bloodgood DW, Hardaway JA, Stanhope CM, Pati D, Pina MM, Neira S et al (2020) Kappa opioid receptor and dynorphin signaling in the central amygdala regulates alcohol intake. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-020-0690-z","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10297_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pharmthera.2009.05.006","volume":"123","author":"C Schwarzer","year":"2009","unstructured":"Schwarzer C (2009) 30 years of dynorphins\u2013new insights on their functions in neuropsychiatric diseases. Pharmacol Ther 123(3):353\u2013370","journal-title":"Pharmacol Ther"},{"issue":"9","key":"10297_CR52","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1093\/cercor\/bhx181","volume":"28","author":"I Bazov","year":"2018","unstructured":"Bazov I, Sarkisyan D, Kononenko O, Watanabe H, Taqi MM, St\u00e5lhandske L et al (2018) Neuronal expression of opioid gene is controlled by dual epigenetic and transcriptional mechanism in human brain. Cereb Cortex 28(9):3129\u20133142","journal-title":"Cereb Cortex"},{"issue":"9","key":"10297_CR53","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/sj.npp.1300959","volume":"31","author":"A Kuzmin","year":"2006","unstructured":"Kuzmin A, Madjid N, Terenius L, Ogren SO, Bakalkin G (2006) Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology 31(9):1928\u20131937","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10297_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.57.1.1","volume":"57","author":"MJ Kreek","year":"2005","unstructured":"Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA (2005) Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57(1):1\u201326","journal-title":"Pharmacol Rev"},{"issue":"17","key":"10297_CR55","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1523\/JNEUROSCI.5492-10.2011","volume":"31","author":"V Trezza","year":"2011","unstructured":"Trezza V, Damsteegt R, Achterberg EJ, Vanderschuren LJ (2011) Nucleus accumbens \u03bc-opioid receptors mediate social reward. J Neurosci 31(17):6362\u20136370","journal-title":"J Neurosci"},{"issue":"6","key":"10297_CR56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00439-012-1172-4","volume":"131","author":"O Levran","year":"2012","unstructured":"Levran O, Yuferov V, Kreek MJ (2012) The genetics of the opioid system and specific drug addictions. Hum Genet 131(6):823\u2013842","journal-title":"Hum Genet"},{"issue":"1","key":"10297_CR57","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0006-8993(87)90121-1","volume":"403","author":"RC Silvia","year":"1987","unstructured":"Silvia RC, Slizgi GR, Ludens JH, Tang AH (1987) Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist. Brain Res 403(1):52\u201357","journal-title":"Brain Res"},{"issue":"5994","key":"10297_CR58","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/312551a0","volume":"312","author":"DS Baskin","year":"1984","unstructured":"Baskin DS, Hosobuchi Y, Loh HH, Lee NM (1984) Dynorphin(1\u201313) improves survival in cats with focal cerebral ischaemia. Nature 312(5994):551\u2013552","journal-title":"Nature"},{"key":"10297_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1113\/jphysiol.1986.sp016184","volume":"377","author":"RL Macdonald","year":"1986","unstructured":"Macdonald RL, Werz MA (1986) Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones. J Physiol 377:237\u2013249","journal-title":"J Physiol"},{"issue":"17","key":"10297_CR60","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1523\/JNEUROSCI.17-17-06565.1997","volume":"17","author":"KI Rusin","year":"1997","unstructured":"Rusin KI, Giovannucci DR, Stuenkel EL, Moises HC (1997) Kappa-opioid receptor activation modulates Ca2+ currents and secretion in isolated neuroendocrine nerve terminals. J Neurosci 17(17):6565\u20136574","journal-title":"J Neurosci"},{"issue":"4","key":"10297_CR61","first-page":"437","volume":"5","author":"KF Hauser","year":"1998","unstructured":"Hauser KF, Mangoura D (1998) Diversity of the endogenous opioid system in development. Novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation. Perspect Dev Neurobiol 5(4):437\u2013449","journal-title":"Perspect Dev Neurobiol"},{"issue":"2","key":"10297_CR62","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/glia.1080","volume":"35","author":"PE Knapp","year":"2001","unstructured":"Knapp PE, Itkis OS, Zhang L, Spruce BA, Bakalkin G, Hauser KF (2001) Endogenous opioids and oligodendroglial function: possible autocrine\/paracrine effects on cell survival and development. Glia 35(2):156\u2013165","journal-title":"Glia"},{"issue":"1","key":"10297_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0143-4179(98)90022-1","volume":"32","author":"RM Caudle","year":"1998","unstructured":"Caudle RM, Dubner R (1998) Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1\u201317 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus. Neuropeptides 32(1):87\u201395","journal-title":"Neuropeptides"},{"issue":"2\u20133","key":"10297_CR64","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0304-3940(98)00293-6","volume":"247","author":"SL Lai","year":"1998","unstructured":"Lai SL, Gu Y, Huang LY (1998) Dynorphin uses a non-opioid mechanism to potentiate N-methyl-d-aspartate currents in single rat periaqueductal gray neurons. Neurosci Lett 247(2\u20133):115\u2013118","journal-title":"Neurosci Lett"},{"issue":"6","key":"10297_CR65","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1523\/JNEUROSCI.15-06-04602.1995","volume":"15","author":"L Chen","year":"1995","unstructured":"Chen L, Gu Y, Huang LY (1995) The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J Neurosci 15(6):4602\u20134611","journal-title":"J Neurosci"},{"issue":"2","key":"10297_CR66","first-page":"760","volume":"291","author":"Q Tang","year":"1999","unstructured":"Tang Q, Gandhoke R, Burritt A, Hruby VJ, Porreca F, Lai J (1999) High-affinity interaction of (des-Tyrosyl)dynorphin A(2\u201317) with NMDA receptors. J Pharmacol Exp Ther 291(2):760\u2013765","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10297_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0006-8993(02)03180-3","volume":"952","author":"K Tan-No","year":"2002","unstructured":"Tan-No K, Esashi A, Nakagawasai O, Niijima F, Tadano T, Sakurada C et al (2002) Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-d-aspartate receptor mechanism. Brain Res 952(1):7\u201314","journal-title":"Brain Res"},{"issue":"2","key":"10297_CR68","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.peptides.2012.04.006","volume":"35","author":"H Watanabe","year":"2012","unstructured":"Watanabe H, Mizoguchi H, Verbeek DS, Kuzmin A, Nyberg F, Krishtal O et al (2012) Non-opioid nociceptive activity of human dynorphin mutants that cause neurodegenerative disorder spinocerebellar ataxia type 23. Peptides 35(2):306\u2013310","journal-title":"Peptides"},{"issue":"11","key":"10297_CR69","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.neurobiolaging.2006.07.002","volume":"28","author":"T Yakovleva","year":"2007","unstructured":"Yakovleva T, Marinova Z, Kuzmin A, Seidah NG, Haroutunian V, Terenius L et al (2007) Dysregulation of dynorphins in Alzheimer disease. Neurobiol Aging 28(11):1700\u20131708","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10297_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1006\/exnr.2000.7580","volume":"168","author":"KF Hauser","year":"2001","unstructured":"Hauser KF, Knapp PE, Turbek CS (2001) Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites. Exp Neurol 168(1):78\u201387","journal-title":"Exp Neurol"},{"issue":"45","key":"10297_CR71","doi-asserted-by":"publisher","first-page":"14371","DOI":"10.1523\/JNEUROSCI.2186-09.2009","volume":"29","author":"TW Sherwood","year":"2009","unstructured":"Sherwood TW, Askwith CC (2009) Dynorphin opioid peptides enhance acid-sensing ion channel 1a activity and acidosis-induced neuronal death. J Neurosci 29(45):14371\u201314380","journal-title":"J Neurosci"},{"issue":"13","key":"10297_CR72","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1016\/j.febslet.2006.04.078","volume":"580","author":"L Hugonin","year":"2006","unstructured":"Hugonin L, Vukojevi\u0107 V, Bakalkin G, Gr\u00e4slund A (2006) Membrane leakage induced by dynorphins. FEBS Lett 580(13):3201\u20133205","journal-title":"FEBS Lett"},{"issue":"1","key":"10297_CR73","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbrc.2011.06.105","volume":"411","author":"F Madani","year":"2011","unstructured":"Madani F, Taqi MM, W\u00e4rml\u00e4nder SK, Verbeek DS, Bakalkin G, Gr\u00e4slund A (2011) Perturbations of model membranes induced by pathogenic dynorphin A mutants causing neurodegeneration in human brain. Biochem Biophys Res Commun 411(1):111\u2013114","journal-title":"Biochem Biophys Res Commun"},{"issue":"28","key":"10297_CR74","doi-asserted-by":"publisher","first-page":"26360","DOI":"10.1074\/jbc.M412494200","volume":"280","author":"Z Marinova","year":"2005","unstructured":"Marinova Z, Vukojevic V, Surcheva S, Yakovleva T, Cebers G, Pasikova N et al (2005) Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission. J Biol Chem 280(28):26360\u201326370","journal-title":"J Biol Chem"},{"issue":"5","key":"10297_CR75","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.bbamem.2008.02.003","volume":"1778","author":"L Hugonin","year":"2008","unstructured":"Hugonin L, Vukojevi\u0107 V, Bakalkin G, Gr\u00e4slund A (2008) Calcium influx into phospholipid vesicles caused by dynorphin neuropeptides. Biochim Biophys Acta 1778(5):1267\u20131273","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"10297_CR76","first-page":"2728","volume":"25","author":"CJ Smeets","year":"2016","unstructured":"Smeets CJ, Zmorzy\u0144ska J, Melo MN, Stargardt A, Dooley C, Bakalkin G et al (2016) Altered secondary structure of Dynorphin A associates with loss of opioid signalling and NMDA-mediated excitotoxicity in SCA23. Hum Mol Genet 25(13):2728\u20132737","journal-title":"Hum Mol Genet"},{"key":"10297_CR77","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nbd.2018.10.014","volume":"121","author":"M Watanave","year":"2019","unstructured":"Watanave M, Hoshino C, Konno A, Fukuzaki Y, Matsuzaki Y, Ishitani T et al (2019) Pharmacological enhancement of retinoid-related orphan receptor \u03b1 function mitigates spinocerebellar ataxia type 3 pathology. Neurobiol Dis 121:263\u2013273","journal-title":"Neurobiol Dis"},{"key":"10297_CR78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neulet.2018.02.004","volume":"688","author":"M Huang","year":"2019","unstructured":"Huang M, Verbeek DS (2019) Why do so many genetic insults lead to Purkinje cell degeneration and spinocerebellar ataxia? Neurosci Lett 688:49\u201357","journal-title":"Neurosci Lett"},{"issue":"2","key":"10297_CR79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/1570159X15666170529104000","volume":"16","author":"E Shimobayashi","year":"2018","unstructured":"Shimobayashi E, Kapfhammer JP (2018) Calcium signaling, PKC gamma, IP3R1 and CAR8 link spinocerebellar Ataxias and Purkinje cell dendritic development. Curr Neuropharmacol 16(2):151\u2013159","journal-title":"Curr Neuropharmacol"},{"issue":"11","key":"10297_CR80","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/brain\/awx251","volume":"140","author":"EAR Nibbeling","year":"2017","unstructured":"Nibbeling EAR, Duarri A, Verschuuren-Bemelmans CC, Fokkens MR, Karjalainen JM, Smeets C et al (2017) Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia. Brain 140(11):2860\u20132878","journal-title":"Brain"},{"key":"10297_CR81","doi-asserted-by":"publisher","first-page":"e04193","DOI":"10.1085\/jgp.201912390","volume":"3","author":"H Yan","year":"2014","unstructured":"Yan H, Pablo JL, Wang C, Pitt GS (2014) FGF14 modulates resurgent sodium current in mouse cerebellar Purkinje neurons. Elife 3:e04193. https:\/\/doi.org\/10.1085\/jgp.201912390","journal-title":"Elife"},{"issue":"5","key":"10297_CR82","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/mds.23698","volume":"26","author":"T Schmitz-H\u00fcbsch","year":"2011","unstructured":"Schmitz-H\u00fcbsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, D\u00fcrr A et al (2011) Depression comorbidity in spinocerebellar ataxia. Mov Disord 26(5):870\u2013876","journal-title":"Mov Disord"},{"issue":"2","key":"10297_CR83","first-page":"25","volume":"4","author":"DD Bushart","year":"2016","unstructured":"Bushart DD, Murphy GG, Shakkottai VG (2016) Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease. Ann Transl Med 4(2):25","journal-title":"Ann Transl Med"},{"issue":"8","key":"10297_CR84","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/mds.27782","volume":"34","author":"DR Scoles","year":"2019","unstructured":"Scoles DR, Pulst SM (2019) Antisense therapies for movement disorders. Mov Disord 34(8):1112\u20131119","journal-title":"Mov Disord"},{"issue":"6","key":"10297_CR85","first-page":"707","volume":"15","author":"DR Scoles","year":"2018","unstructured":"Scoles DR, Pulst SM (2018) Oligonucleotide therapeutics in neurodegenerative diseases. RNA Biol 15(6):707\u2013714","journal-title":"RNA Biol"},{"issue":"2","key":"10297_CR86","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/jnc.14309","volume":"145","author":"EA Thomas","year":"2018","unstructured":"Thomas EA, D\u2019Mello SR (2018) Complex neuroprotective and neurotoxic effects of histone deacetylases. J Neurochem 145(2):96\u2013110","journal-title":"J Neurochem"},{"issue":"7","key":"10297_CR87","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S1474-4422(16)00099-5","volume":"15","author":"HH Kampinga","year":"2016","unstructured":"Kampinga HH, Bergink S (2016) Heat shock proteins as potential targets for protective strategies in neurodegeneration. Lancet Neurol 15(7):748\u2013759","journal-title":"Lancet Neurol"},{"key":"10297_CR88","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-444-64189-2.00015-9","volume":"155","author":"M Serrano","year":"2018","unstructured":"Serrano M (2018) Epigenetic cerebellar diseases. Handb Clin Neurol 155:227\u2013244","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10297_CR89","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1113\/JP272950","volume":"595","author":"AN Shuvaev","year":"2017","unstructured":"Shuvaev AN, Hosoi N, Sato Y, Yanagihara D, Hirai H (2017) Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice. J Physiol 595(1):141\u2013164","journal-title":"J Physiol"},{"issue":"3","key":"10297_CR90","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jnnp-2019-322168","volume":"91","author":"M Nishizawa","year":"2020","unstructured":"Nishizawa M, Onodera O, Hirakawa A, Shimizu Y, Yamada M (2020) Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials. J Neurol Neurosurg Psychiatry 91(3):254\u2013262","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10297_CR91","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.clinph.2018.06.003","volume":"129","author":"R Rodr\u00edguez-Labrada","year":"2018","unstructured":"Rodr\u00edguez-Labrada R, Vel\u00e1zquez-P\u00e9rez L, Ziemann U (2018) Transcranial magnetic stimulation in hereditary ataxias: diagnostic utility, pathophysiological insight and treatment. Clin Neurophysiol 129(8):1688\u20131698","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"10297_CR92","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3727\/096368916X694373","volume":"26","author":"YA Tsai","year":"2017","unstructured":"Tsai YA, Liu RS, Lirng JF, Yang BH, Chang CH, Wang YC et al (2017) Treatment of spinocerebellar Ataxia with mesenchymal stem cells: a phase I\/IIa clinical study. Cell Transplant 26(3):503\u2013512","journal-title":"Cell Transplant"},{"issue":"7","key":"10297_CR93","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.nrl.2015.06.004","volume":"32","author":"MH Orozco-Guti\u00e9rrez","year":"2017","unstructured":"Orozco-Guti\u00e9rrez MH, Cervantes-Arag\u00f3n I, Garc\u00eda-Cruz D (2017) Ethical considerations in presymptomatic diagnosis of autosomal dominant spinocerebellar ataxias. Neurologia 32(7):469\u2013475","journal-title":"Neurologia"},{"issue":"3","key":"10297_CR94","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12687-015-0235-3","volume":"6","author":"AS do Nascimento-Marinho","year":"2015","unstructured":"do Nascimento-Marinho AS, de Faria-Domingues-de-Lima MA, Vargas FR (2015) Analysis of pre-test interviews in a cohort of Brazilian patients with movement disorders. J Community Genet 6(3):259\u2013264","journal-title":"J Community Genet"},{"issue":"8","key":"10297_CR95","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/mds.27739","volume":"34","author":"A Diallo","year":"2019","unstructured":"Diallo A, Jacobi H, Cook A, Giunti P, Parkinson MH, Labrum R et al (2019) Prediction of survival with long-term disease progression in most common Spinocerebellar ataxia. Mov Disord 34(8):1220\u20131227","journal-title":"Mov Disord"},{"issue":"9","key":"10297_CR96","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/14737175.2017.1364628","volume":"17","author":"L Sarro","year":"2017","unstructured":"Sarro L, Nanetti L, Castaldo A, Mariotti C (2017) Monitoring disease progression in spinocerebellar ataxias: implications for treatment and clinical research. Expert Rev Neurother 17(9):919\u2013931","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10297_CR97","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1212\/WNL.0000000000001711","volume":"85","author":"RP Maas","year":"2015","unstructured":"Maas RP, van Gaalen J, Klockgether T, van de Warrenburg BP (2015) The preclinical stage of spinocerebellar ataxias. Neurology 85(1):96\u2013103","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10297-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10297-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10297-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T05:04:19Z","timestamp":1635915859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10297-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10297"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10297-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"16 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}